Michael Engsig
Chief Executive Officer en NYKODE THERAPEUTICS .
Fortuna: 19 136 $ al 30/04/2024
Cargos activos de Michael Engsig
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NYKODE THERAPEUTICS | Chief Executive Officer | 01/03/2007 | - |
| Investor Relations Contact | 01/03/2007 | - | |
| FLUOGUIDE A/S | Director/Board Member | 01/01/2023 | - |
Historial de carrera de Michael Engsig
Antiguos cargos conocidos de Michael Engsig.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - | - |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Chief Tech/Sci/R&D Officer | - | - |
Formación de Michael Engsig.
| Technical University of Denmark | Graduate Degree |
Estadísticas
Internacional
| Dinamarca | 5 |
| Noruega | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 1 |
| Chief Executive Officer | 1 |
| Investor Relations Contact | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| NYKODE THERAPEUTICS | Health Technology |
| FLUOGUIDE A/S | Health Technology |
| Empresas privadas | 2 |
|---|---|
KLIFO A/S
KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Commercial Services |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Finance |
- Bolsa de valores
- Insiders
- Michael Engsig
- Experiencia
